Bai-rong Xia
Bengbu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer.
Journal: Frontiers in pharmacology
Published: December 24, 2022
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.
Journal: Frontiers in oncology
Published: March 12, 2022
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Journal: Frontiers in immunology
Published: April 19, 2021
Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.
Journal: Frontiers in cell and developmental biology
Published: March 13, 2021
Exosomes: Powerful weapon for cancer nano-immunoengineering.
Journal: Biochemical pharmacology
Published: November 19, 2020
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Journal: Frontiers in oncology
Published: October 12, 2020
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.
Journal: Frontiers in immunology
Published: June 30, 2020
E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
Journal: Cancer cell international
Published: May 15, 2020
Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.
Journal: Cancer cell international
Published: October 05, 2019
Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers.
Journal: Frontiers in oncology
Published: July 10, 2019
Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms.
Journal: Frontiers in oncology
Published: September 24, 2018
Last Updated: 09/26/2026